ProcureCon Pharma US 2016

October 26-October 28, 2016

Contact Us: 1.888.482.6012

Using Procurement to Drive Value in Today’s Fluctuating Pharma Industry

08:15 AM - 09:00 AM Continental Breakfast & Registration



09:00 AM - 09:05 AM Welcome Remarks From The Program Director

Elizabeth Robillard, Program Director, ProcureCon Pharma
Join Elizabeth Robillard, program director for ProcureCon Pharma, as she kicks off the first day of the event!
img

Elizabeth Robillard

Program Director
ProcureCon Pharma

09:05 AM - 09:30 AM Getting To Know You: Procurement Practitioners Ice Breaker

Elizabeth Robillard, Program Director, ProcureCon Pharma
Join program director Elizabeth Robillard as she leads attendees through a short getting to know you ice breaker consisting of a Philly fun facts trivia game.
img

Elizabeth Robillard

Program Director
ProcureCon Pharma

09:30 AM - 10:00 AM Category Management in Clinical Development – How to Determine the Best Sourcing Approach for your Organization

David Freschi, Senior Director, R&D Procurement & Clinical Outsourcing, Regeneron Pharmaceuticals, Inc. Ratan Ratnesh, Director, Clinical Outsourcing, Otsuka Pharmaceutical Companies (U.S.)
Given the sensitive nature of clinical trials, the way they are purchased and the agreements involved can be cumbersome and complicated. Dave Freschi and Ratan Ratnesh will walk us through best practices involved with sourcing this expensive category specifically. They will talk about things like:

-Ranking and evaluating key outsourcing variables — the money, the contract and the people
-Understanding the perspective of legal, compliance and R&D before conducting research on perspective suppliers and analyze criteria and considerations for vetting CMOs
-Reviewing potential vendors, requesting proposals (what info should be included)
-Writing up outsourcing specific contracts and coming up with long term KPI’s to evaluate vendors you choose to work with
-What is the lifecycle of an outsourcing engagement? How does that evolve over time?
img

David Freschi

Senior Director, R&D Procurement & Clinical Outsourcing
Regeneron Pharmaceuticals, Inc.
img

Ratan Ratnesh

Director, Clinical Outsourcing
Otsuka Pharmaceutical Companies (U.S.)
Clinical and non-clinical activities as they relate to R&D are by and large the biggest categories of indirect spend for biopharma. With so many investments being made in drug development, how can procurement better support innovation and drive efficiency? This session will look at how procurement can:

-Create value in an environment where speed, trust and quality are the key currencies
-Find opportunities to drive productivity across the organization to support the science
-Collaborate internally to simplify processes to cut down cycle time --Develop an innovation marketplace to simplify the search for suppliers
-Embed information on supplier and services to share knowledge globally
-Reduce cycle time in R&D, leading to significant cost reduction
img

Frank Tamburro

Sr. Manager, Scientific Services Strategic Sourcing
Amgen Inc
img

Donna Lynch

Director, R&d Clinical Procurement, Cro & Clinical Monitoring Global Lead
GlaxoSmithKline

Fred Naids

Head of Global R&D Procurement
Shire
img

Rea Tachdjian, C.P.M

Former Sourcing Manager, Global R&D, Janssen
Procurement Management Leader

10:45 AM - 11:05 AM Welcome to the Future of Procurement: Vision 2020

Richard Stack, VP, Value Engineering, SAP Ariba
Imagine it's the year 2020. Procurement has evolved so much over the past decade, you barely recognize it. Its functions have been decentralized – or outsourced! – leaving leadership to focus on very different things. Job descriptions have changed dramatically. What's more, suppliers seem to have infiltrated the organization. Today’s focus on cost savings will give way to a broader, more balanced emphasis on profitability, leaving open the question of whether supply management concentrates on cost savings or revenue growth to get there.
img

Richard Stack

VP, Value Engineering
SAP Ariba

11:05 AM - 11:25 AM A Look Into The Strategic Nature of Market and Risk Intelligence at BMS

Miriam Limbach, Head of Procurement, Bayer HealthCare
Richard Dean serves in Bristol-Myers Squibb’s Center of Excellence focused on global procurement market and risk intelligence analytics. His research supports an array of spend categories with actionable supplier capability assessments and performance scorecards that foster stronger relationships between Bristol-Myers Squibb and its worldwide supply base. Mr. Dean’s presentation will offer a case study view of the strategic nature of market and risk intelligence at BMS and how this function supports both better decision making and mutually beneficial customer-supplier outcomes.
img

Miriam Limbach

Head of Procurement
Bayer HealthCare

11:25 AM - 12:00 PM Morning Refreshment & Networking Break

Join your peers for the first of many networking breaks at ProcureCon Pharma. Chat over a coffee about what issues or concerns are top of mind for you in procurement and discuss what can be used to alleviate these.

Working Group A

12:00 PM - 1:00 PM Moving from Early to Middle Maturity Working Group

If you’re in the middle of your procurement transformation process, but are getting stuck or hitting roadblocks, what can you do to move your maturity level to be in line with your competitors or companies of similar size? Attendees will break into these working group sessions and craft an action plan of five ideas or takeaways that you can implement immediately to begin getting results back in the office. The action plans will be reported back to the entire group during the afternoon sessions. Each group is limited to 30 participants to ensure practical takeaways.

Moving from Early to Middle Maturity Working Group
Those in this group will be either just getting their procurement organization off the ground or will be in early stages of the following functions:
Transaction Focus: Supply Assurance; Price Negotiation
Spend Focus: Total Cost; Consolidation; Compliance

Working Group B

12:00 PM - 1:00 PM Moving From Middle to Fully Mature Working Group

Attendees will break into these working group sessions and craft an action plan of five ideas or takeaways that you can implement immediately to begin getting results back in the office. The action plans will be reported back to the entire group during the afternoon sessions. Each group is limited to 30 participants to ensure practical takeaways.

Moving From Middle to Fully Mature
Those in this group will be well on their way towards procurement maturity, and have organizations fully formed that focus on the fundamentals learned in early maturity, but are also tackling the following next steps:
Product Focus: Demand Management; Performance Supplier Involvement
Process Focus: Efficiency; Business Involvement

*Bonus! If you already consider yourself to be a mature organization, look at how to be tackling the following points
- o Value Focus: Total Creation & Collaboration

1:00 PM - 2:10 PM Lunch for all attendees



Now that you’ve got the eyes and ears of internal business owners, how will you make the most of this opportunity? How can you work more closely to deliver the most value to the business? This panel discussion will explore:

-Marketing your procurement organization as a peer function who can bring solutions to the table, not just a support function looking to disrupt things
-Making sure they understand that while you are looking to save costs, you are also hoping to help mitigate risk and ensure all aspects of the business run more efficiently- thus improving quality and speed to market for their products
-Building credibility with internal stakeholders so they trust to bring you into business/resourcing decisions right at the beginning of the discussion
-Ensuring there is ongoing communication and transparency with stakeholders through business review meetings where you can be better understanding their goals and get visibility into their budgets

After 40 minutes of panel discussion onstage, we will be taking the panel to the audience and will ask small groups in the audience to discuss the panel topics- giving you a chance to be a bit more interactive!

img

Michelle Charpentier

Director, Global Indirect Procurement
BioMarin Pharmaceutical Inc.
img

Adam Long

Head of Indirect
Merrimack
img

Kent Morsch

Regional Head of Procurement
Takeda Pharmaceuticals
img

Rea Tachdjian, C.P.M

Former Sourcing Manager, Global R&D, Janssen
Procurement Management Leader

3:00 PM - 3:10 PM Report Back on Working Groups

Led by each facilitator from the morning working groups. They will share key learnings with the whole audience.

3:10 PM - 3:55 PM Afternoon Refreshment & Networking Break in the Solutions Lounge

Take a break, have a cup of coffee and explore the Networking Lounge. This is your home base for refreshments, snacks and chance to check out the latest technology and solutions to streamline your procurement processes and deliver maximum value to your organization.

3:55 PM - 4:15 PM Using Science Exchange To Drive Innovation and Efficiency at a Top 10 Biopharmaceutical Company

Dr. Elizabeth Iorns, Founder & CEO, Science Exchange
In 2015 a top 10 biopharmaceutical company implemented the technology platform Science Exchange to improve performance in the category of outsourced scientific services. The biopharma company has consolidated its preclinical and discovery research outsourcing tail-spend ($10 million, 100 suppliers) into one strategic supplier relationship. This drove significant direct (10% ) and indirect cost savings and improved scientific productivity and access to innovation.
img

Dr. Elizabeth Iorns

Founder & CEO
Science Exchange
M&A activity and shifts in the global economy are pushing procurement to be more nimble and agile than ever before. Regardless of the maturity of your procurement department, or the size of your organization, the need to swiftly and smartly react to major business changes is paramount. Join this panel to learn more about: -Having a plan in place to address M&A before it happens -Gaining transparency of the supply chain you’re inheriting and its risks -Reviewing contracts and how they will affect spend in other divisions -Synergizing suppliers common to both companies -Engaging Employees to make sure they get what is happening and don’t feel out of the loop -Having frequent opportunities for the company to gather and discuss M&A pain points
img

Jon Leisner

Assistant Director, Sourcing and Facilities
Albany Molecular Research Inc. (AMRI)
img

Phil Sampona

Senior Global Category Procurement Manager
FMC Corporation
img

Brett Healy

Director Global Procurement
Capsugel

5:00 PM - 6:00 PM Cocktail Reception in the Solution's Lounge

After a busy day of interactive, solution-focused workshops, relax with fellow speakers and attendees.

6:00 PM - 5:00 PM End of Procurement Executives Only Day